U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07808788) titled 'A Research Study Looking Into How a Single Dose of the Medicine NNC0537-1482 Moves Through... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07810283) titled 'The Feasibility of Electrical Impedance Tomography to Guide Non-invasive Respiratory Inter... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07810569) titled 'Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic Patients' on Sept.... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07809646) titled 'Cl-Pharm-IBS-ML-2026' on Sept. 03. Brief Summary: The purpose of this study is to identif... Read More
Singapore, Sept. 10 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07809724) titled 'Efficacy and Safety of Low-Dose IL-2 in Neuromyelitis Optica Spectrum Disorder' on Jan. 23... Read More
Singapore, Sept. 10 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07808593) titled 'Artificial Intelligence - Based Opportunistic Coronary Artery Calcium Scoring on Routine C... Read More
Singapore, Sept. 10 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asci... Read More
Singapore, Sept. 10 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib wit... Read More